Acknowledgements
We would like to thank Zahida Qureshi and Jenipher Okore (Kenya), Hadiza
Galadanci and Aminu Ado Wakili (Nigeria), Elani Muller (South-Africa),
and Fadhlun M. Alwy Al-beity and Juma Makungu (Tanzania), for their help
with local sample collection.
Disclosure of InterestsRelated to the present study AA and AMG report a BMGF grant to the
University of Birmingham for Concept Foundation. Outside the study, AA
and AMG report a grant from the BMGF to Concept Foundation for
landscaping the need for accelerating innovation for mothers. AA and AMG
report funding from MSD for Mothers paid to the Concept Foundation. PL
reports grant funding from Johnson & Johnson, the Victoria Medical
Research Acceleration Fund and the Australian Federal Government
Accelerating Commercialisation Programme to Monash University to support
development of a heat- stable inhaled oxytocin product for management of
PPH in low- resource settings. Other authors report no conflicts of
interest.